FDA Approves First Once-Daily HIV Pill | Business and Finance News

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded28 Aug 2026

Publisherfeeds.acast.com ↗

Handlerec:20169843

Show notes

FDA just approved Gilead’s new once-daily HIV pill, Bixlenvo — the first single-tablet option for adults with suppressed HIV who can’t use existing one-pill treatments. Combining bictegravir and groundbreaking lenacapavir, it simplifies regimens for those managing drug resistance or side effects from older meds, especially as they age. Two major studies confirmed its effectiveness in maintaining viral suppression and showed it’s generally well-tolerated. This marks a key step in Gilead’s mission to offer flexible, patient-centered HIV treatment options — from pills to injections — empowering people to choose what works best for their lives. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/13070209ef1489d5

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.